How CROs are Uniquely Positioned to Drive Adoption of the TMF Exchange Mechanism

Felix Arellano
Global Head of Drug Safety – Roche

‘From Planning to Launch: How to Implement a New Safety Database and Maximize ROI’

Hans van Leeuwen
Global Head of Regulatory Operations – Astellas

‘Achieving Interoperable Safety and Regulatory Platforms’

Julie Thomas
Vice President, Global Medical Safety Operations – Johnson & Johnson

‘LifeSphere NavaX: Driving Greater Value with GenAI’

Blog

How CROs are Uniquely Positioned to Drive Adoption of the TMF Exchange Mechanism

July 14, 2022

Our Director of Product Marketing – Clinical, Art Brown, shares insights on the CRO opportunity with TMF exchange. Read more on Applied Clinical Trials here.

What’s New?

Discover NavaX

the latest automation from LifeSphere

Learn More

ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.

Quick Links

Follow Us

‘From Planning to Launch: How to Implement a New Safety Database and Maximize ROI’

‘Achieving Interoperable Safety and Regulatory Platforms’

‘LifeSphere NavaX: Driving Greater Value with GenAI’

How CROs are Uniquely Positioned to Drive Adoption of the TMF Exchange Mechanism

Share on LinkedIn

Related Posts

Taking the pulse: how ready is the Regulatory function for AI-enabled reinvention?

5 Reasons You Can’t Miss Breakthrough 2025

What to Expect and What’s Trending in Regulatory Affairs

6 Ways to Discover Greater Value from Your Safety Platform

What’s New?

Discover NavaX